Peterson Kristine's Insider Trades & SAST Disclosures
Peterson Kristine's most recent trade in Enanta Pharmaceuticals Inc was a trade of 15,700 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Peterson Kristine.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Enanta Pharmaceuticals Inc | Kristine Peterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 15,700 | 15,700 | - | - | Stock Option (right to buy) | |
| Immunocore Holdings plc - ADR | Kristine Peterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 14,534 | 14,534 | - | - | Share Option (Right to Buy) | |
| ArriVent BioPharma Inc. | Kristine Peterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2024 | 28,587 | 28,587 | - | - | Stock Option (right to buy) | |
| Enanta Pharmaceuticals Inc | Kristine Peterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 15,700 | 15,700 | - | - | Stock Option (right to buy) | |
| Immunogen, Inc. | Kristine Peterson | Director | Sale of securities on an exchange or to another person at price $ 28.90 per share. | 30 Nov 2023 | 20,000 | 0 (0%) | 0% | 28.9 | 578,000 | Common Stock |
| Immunogen, Inc. | Kristine Peterson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2023 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Immunogen, Inc. | Peterson Kristine | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.07 per share. | 30 Nov 2023 | 10,000 | 20,000 (0%) | 0% | 13.1 | 130,700 | Common Stock |
| Immunogen, Inc. | Peterson Kristine | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2023 | 10,000 | 0 | - | - | Stock Option (right to buy) | |
| Immunogen, Inc. | Peterson Kristine | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.10 per share. | 30 Nov 2023 | 10,000 | 10,000 (0%) | 0% | 10.1 | 101,000 | Common Stock |
| Immunogen, Inc. | Kristine Peterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 19,597 | 19,597 | - | - | Stock Option (right to buy) | |
| Immunogen, Inc. | Kristine Peterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 13,090 | 13,090 | - | - | Restricted Stock Unit | |
| Enanta Pharmaceuticals Inc | Kristine Peterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 10,800 | 10,800 | - | - | Stock Option (right to buy) | |
| Paratek Pharmaceuticals Inc. | Kristine Peterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 20,000 | 79,000 (0%) | 0% | 0 | Common Stock | |
| Immunogen, Inc. | Kristine Peterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Immunogen, Inc. | Kristine Peterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 15,000 | 74,954 | - | - | Deferred Share Unit | |
| Enanta Pharmaceuticals Inc | Kristine Peterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
| Paratek Pharmaceuticals Inc. | Kristine Peterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 20,000 | 59,000 (0%) | 0% | 0 | Common Stock | |
| Immunogen, Inc. | Kristine Peterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Immunogen, Inc. | Kristine Peterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 15,000 | 59,954 | - | - | Deferred Share Unit | |
| Enanta Pharmaceuticals Inc | Kristine Peterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
| Paratek Pharmaceuticals Inc. | Kristine Peterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 9,000 | 39,000 (0%) | 0% | 0 | Common Stock | |
| Paratek Pharmaceuticals Inc. | Kristine Peterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 7,000 | 7,000 | - | - | Stock Option (right to buy) | |
| Immunogen, Inc. | Kristine Peterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Immunogen, Inc. | Kristine Peterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 17,000 | 44,954 | - | - | Deferred Share Unit |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges